Skip to main content
Top
Published in: International Journal of Legal Medicine 6/2016

01-11-2016 | Original Article

Determination of the unbound fraction of R- and S-methadone in human brain

Authors: Karen M. D. Holm, Kristian Linnet

Published in: International Journal of Legal Medicine | Issue 6/2016

Login to get access

Abstract

According to the free drug hypothesis, only the unbound fraction (f u ) of a given drug is biologically available in terms of its pharmacologic activity. Methadone shows large interpersonal variation in toxicity. The goal of the work presented here was to examine whether isolating the unbound fraction of the active R-methadone enantiomer from brain matter could be of value as a forensic tool. A method applying equilibrium dialysis to postmortem brain samples was validated and showed good reproducibility for the previously published f u values for eight common drugs (alprazolam, citalopram, codeine, methadone, morphine, diazepam, oxycodone, tramadol), as well as methadone enantiomers. This method was then applied to approximately 50 authentic case samples with R-methadone and S-methadone concentrations ranging from 0.03 to 13 and 0.6 to 6.8 mg/kg, respectively; median f u values (R-and S-methadone) were 3.9 % (range 3.0–5.3 %) and 3.7 % (range 2.9–4.9 %). No overall correlation between the active R-methadone concentration and f u were found. Small but statistically significant differences in median f u for the R-methadone enantiomer were identified between case-categories (i.e., poisoning with multiple drugs, methadone poisoning, and deaths unrelated to methadone), but these are thought to be too low to be of any forensic value.
Literature
3.
go back to reference de Vos JW, Ufkes JG, Kaplan CD, Tursch M, Krause JK, van Wilgenburg H, Woodcock BG, Staib AH (1998) L-Methadone and D, L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations. Eur Addict Res 4:134–141. doi:10.1159/000018936 CrossRefPubMed de Vos JW, Ufkes JG, Kaplan CD, Tursch M, Krause JK, van Wilgenburg H, Woodcock BG, Staib AH (1998) L-Methadone and D, L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations. Eur Addict Res 4:134–141. doi:10.​1159/​000018936 CrossRefPubMed
5.
go back to reference Stimpfl T (2008) Drugs-of-abuse testing in brain. In: Jenkins AJ (ed) Drug testing in alternate biological specimens, 1st edn. Humana Press, Totowa, pp 157–180CrossRef Stimpfl T (2008) Drugs-of-abuse testing in brain. In: Jenkins AJ (ed) Drug testing in alternate biological specimens, 1st edn. Humana Press, Totowa, pp 157–180CrossRef
7.
go back to reference Gupta A, Chatelain P, Massingham R, Jonsson EN, Hammarlund-Udenaes M (2006) Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p, u), and K(p, uu). Drug Metab Dispos 34:318–323. doi:10.1124/dmd.105.007211 CrossRefPubMed Gupta A, Chatelain P, Massingham R, Jonsson EN, Hammarlund-Udenaes M (2006) Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p, u), and K(p, uu). Drug Metab Dispos 34:318–323. doi:10.​1124/​dmd.​105.​007211 CrossRefPubMed
8.
go back to reference Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (2004) Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology 173:132–138. doi:10.1007/s00213-003-1718-1 CrossRefPubMed Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (2004) Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology 173:132–138. doi:10.​1007/​s00213-003-1718-1 CrossRefPubMed
9.
10.
go back to reference Polli JW, Baughman TM, Humphreys JE, Jordan KH, Mote AL, Salisbury JA, Tippin TK, Serabjit-Singh CJ (2003) P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine. J Pharm Sci 92:2082–2089. doi:10.1002/jps.10453 CrossRefPubMed Polli JW, Baughman TM, Humphreys JE, Jordan KH, Mote AL, Salisbury JA, Tippin TK, Serabjit-Singh CJ (2003) P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine. J Pharm Sci 92:2082–2089. doi:10.​1002/​jps.​10453 CrossRefPubMed
11.
go back to reference Liu SJ, Roerig DL, Wang RIH (1983) Brain and plasma-levels of methadone and their relationships to analgesic activity of methadone in rats. Drug Metab Dispos 11:335–338PubMed Liu SJ, Roerig DL, Wang RIH (1983) Brain and plasma-levels of methadone and their relationships to analgesic activity of methadone in rats. Drug Metab Dispos 11:335–338PubMed
14.
go back to reference Rodriguez-Rosas ME, Medrano JG, Epstein DH, Moolchan ET, Preston KL, Wainer IW (2005) Determination of total and free concentrations of the enantiomers of methadone and its metabolite (2-ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine) in human plasma by enantioselective liquid chromatography with mass spectrometric detection. J Chromatogr A 1073:237–248. doi:10.1016/j.chroma.2004.08.153 CrossRefPubMed Rodriguez-Rosas ME, Medrano JG, Epstein DH, Moolchan ET, Preston KL, Wainer IW (2005) Determination of total and free concentrations of the enantiomers of methadone and its metabolite (2-ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine) in human plasma by enantioselective liquid chromatography with mass spectrometric detection. J Chromatogr A 1073:237–248. doi:10.​1016/​j.​chroma.​2004.​08.​153 CrossRefPubMed
15.
16.
go back to reference Eap CB, Cuendet C, Baumann P (1990) Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein. Clin Pharmacol Ther 47:338–346. doi:10.1038/clpt.1990.37 CrossRefPubMed Eap CB, Cuendet C, Baumann P (1990) Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein. Clin Pharmacol Ther 47:338–346. doi:10.​1038/​clpt.​1990.​37 CrossRefPubMed
17.
go back to reference Crettol S, Digon P, Golay KP, Brawand M, Eap CB (2007) In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R, S)-methadone, LAAM and their main metabolites. Pharmacology 80:304–311. doi:10.1159/000107104 CrossRefPubMed Crettol S, Digon P, Golay KP, Brawand M, Eap CB (2007) In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R, S)-methadone, LAAM and their main metabolites. Pharmacology 80:304–311. doi:10.​1159/​000107104 CrossRefPubMed
18.
21.
go back to reference Holm KM, Linnet K (2012) Chiral analysis of methadone and its main metabolite, EDDP, in postmortem brain and blood by automated SPE and liquid chromatography-mass spectrometry. J Anal Toxicol 36:487–496. doi:10.1093/jat/bks057 CrossRefPubMed Holm KM, Linnet K (2012) Chiral analysis of methadone and its main metabolite, EDDP, in postmortem brain and blood by automated SPE and liquid chromatography-mass spectrometry. J Anal Toxicol 36:487–496. doi:10.​1093/​jat/​bks057 CrossRefPubMed
22.
go back to reference Diao X, Ma Z, Lei P, Zhong D, Zhang Y, Chen X (2013) Enantioselective determination of 3-n-butylphthalide (NBP) in human plasma by liquid chromatography on a teicoplanin-based chiral column coupled with tandem mass spectrometry. J Chromatogr B 939:67–72. doi:10.1016/j.jchromb.2013.09.014 CrossRef Diao X, Ma Z, Lei P, Zhong D, Zhang Y, Chen X (2013) Enantioselective determination of 3-n-butylphthalide (NBP) in human plasma by liquid chromatography on a teicoplanin-based chiral column coupled with tandem mass spectrometry. J Chromatogr B 939:67–72. doi:10.​1016/​j.​jchromb.​2013.​09.​014 CrossRef
23.
go back to reference Zhou T, Zeng J, Liu S, Zhao T, Wu J, Lai W, He M, Xu B, Qu S, Xu L, Tan W (2015) Study on the determination and chiral inversion of R-salbutamol in human plasma and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B 1002:218–227. doi:10.1016/j.jchromb.2015.08.020 CrossRef Zhou T, Zeng J, Liu S, Zhao T, Wu J, Lai W, He M, Xu B, Qu S, Xu L, Tan W (2015) Study on the determination and chiral inversion of R-salbutamol in human plasma and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B 1002:218–227. doi:10.​1016/​j.​jchromb.​2015.​08.​020 CrossRef
26.
27.
go back to reference Wan H, Rehngren M, Giordanetto F, Bergstrom F, Tunek A (2007) High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. J Med Chem 50:4606–4615. doi:10.1021/jm070375w CrossRefPubMed Wan H, Rehngren M, Giordanetto F, Bergstrom F, Tunek A (2007) High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. J Med Chem 50:4606–4615. doi:10.​1021/​jm070375w CrossRefPubMed
28.
go back to reference Kalvass JC, Maurer TS, Pollack GM (2007) Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos 35:660–666. doi:10.1124/dmd.106.012294 CrossRefPubMed Kalvass JC, Maurer TS, Pollack GM (2007) Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos 35:660–666. doi:10.​1124/​dmd.​106.​012294 CrossRefPubMed
30.
go back to reference Summerfield SG, Stevens AJ, Cutler L, del Carmen OM, Hammond B, Tang SP, Hersey A, Spalding DJ, Jeffrey P (2006) Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther 316:1282–1290. doi:10.1124/jpet.105.092916 CrossRefPubMed Summerfield SG, Stevens AJ, Cutler L, del Carmen OM, Hammond B, Tang SP, Hersey A, Spalding DJ, Jeffrey P (2006) Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther 316:1282–1290. doi:10.​1124/​jpet.​105.​092916 CrossRefPubMed
31.
go back to reference Liu X, Van NK, Yeo H, Vilenski O, Weller PE, Worboys PD, Monshouwer M (2009) Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos 37:787–793. doi:10.1124/dmd.108.024125 CrossRefPubMed Liu X, Van NK, Yeo H, Vilenski O, Weller PE, Worboys PD, Monshouwer M (2009) Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos 37:787–793. doi:10.​1124/​dmd.​108.​024125 CrossRefPubMed
32.
go back to reference Longhi R, Corbioli S, Fontana S, Vinco F, Braggio S, Helmdach L, Schiller J, Boriss H (2011) Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug Metab Dispos 39:312–321. doi:10.1124/dmd.110.036095 CrossRefPubMed Longhi R, Corbioli S, Fontana S, Vinco F, Braggio S, Helmdach L, Schiller J, Boriss H (2011) Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug Metab Dispos 39:312–321. doi:10.​1124/​dmd.​110.​036095 CrossRefPubMed
33.
35.
go back to reference Zamek-Gliszczynski MJ, Ruterbories KJ, Ajamie RT, Wickremsinhe ER, Pothuri L, Rao MV, Basavanakatti VN, Pinjari J, Ramanathan VK, Chaudhary AK (2011) Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs. J Pharm Sci 100:2498–2507. doi:10.1002/jps.22452 CrossRefPubMed Zamek-Gliszczynski MJ, Ruterbories KJ, Ajamie RT, Wickremsinhe ER, Pothuri L, Rao MV, Basavanakatti VN, Pinjari J, Ramanathan VK, Chaudhary AK (2011) Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs. J Pharm Sci 100:2498–2507. doi:10.​1002/​jps.​22452 CrossRefPubMed
36.
go back to reference Bjork MK, Simonsen KW, Andersen DW, Dalsgaard PW, Sigurethardottir SR, Linnet K, Rasmussen BS (2013) Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 405:2607–2617. doi:10.1007/s00216-012-6670-7 CrossRefPubMed Bjork MK, Simonsen KW, Andersen DW, Dalsgaard PW, Sigurethardottir SR, Linnet K, Rasmussen BS (2013) Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 405:2607–2617. doi:10.​1007/​s00216-012-6670-7 CrossRefPubMed
37.
go back to reference Kalvass JC, Maurer TS (2002) Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos 23:327–338. doi:10.1002/bdd.325 CrossRefPubMed Kalvass JC, Maurer TS (2002) Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos 23:327–338. doi:10.​1002/​bdd.​325 CrossRefPubMed
38.
go back to reference Fridén M, Bergstrom F, Wan H, Rehngren M, Ahlin G, Hammarlund-Udenaes M, Bredberg U (2011) Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods. Drug Metab Dispos 39:353–362. doi:10.1124/dmd.110.035998 CrossRefPubMed Fridén M, Bergstrom F, Wan H, Rehngren M, Ahlin G, Hammarlund-Udenaes M, Bredberg U (2011) Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods. Drug Metab Dispos 39:353–362. doi:10.​1124/​dmd.​110.​035998 CrossRefPubMed
39.
go back to reference Summerfield SG, Lucas AJ, Porter RA, Jeffrey P, Gunn RN, Read KR, Stevens AJ, Metcalf AC, Osuna MC, Kilford PJ, Passchier J, Ruffo AD (2008) Toward an improved prediction of human in vivo brain penetration. Xenobiotica 38:1518–1535. doi:10.1080/00498250802499459 CrossRefPubMed Summerfield SG, Lucas AJ, Porter RA, Jeffrey P, Gunn RN, Read KR, Stevens AJ, Metcalf AC, Osuna MC, Kilford PJ, Passchier J, Ruffo AD (2008) Toward an improved prediction of human in vivo brain penetration. Xenobiotica 38:1518–1535. doi:10.​1080/​0049825080249945​9 CrossRefPubMed
41.
go back to reference Gertz M, Kilford PJ, Houston JB, Galetin A (2008) Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations. Drug Metab Dispos 36:535–542. doi:10.1124/dmd.107.018713 CrossRefPubMed Gertz M, Kilford PJ, Houston JB, Galetin A (2008) Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations. Drug Metab Dispos 36:535–542. doi:10.​1124/​dmd.​107.​018713 CrossRefPubMed
Metadata
Title
Determination of the unbound fraction of R- and S-methadone in human brain
Authors
Karen M. D. Holm
Kristian Linnet
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 6/2016
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-016-1365-9

Other articles of this Issue 6/2016

International Journal of Legal Medicine 6/2016 Go to the issue